Trial Profile
To assess the effect of available NRTI backbones in Italy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2018
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir alafenamide (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Lamivudine/abacavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 04 Dec 2018 New trial record
- 14 Nov 2018 Results presented at the 21st Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research